Mitchell P. Kopin 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 11:14 am Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 504,550 4.990% |
349,782 (+226.00%) |
Filing |
| 2024-02-06 10:23 am Sale |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 154,768 6.600% |
-12,371 (-7.40%) |
Filing |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 167,139 7.600% |
167,139 (New Position) |
Filing |